To address this issue, we performed gene expression studies detecting ABCB1, ABCG2, ABCC1, CYP1A2, CYP3A4 and CYP2B6 in systemic and NSCLC cellular models following exposure to tepotinib. Here, ABCC1 is linked to non-small cell lung carcinoma.